品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

Trevigen/Cultrex® BME Cell Invasion Assay/3455-024-K/24 Tests, 96 tests

价格
面议
货号:3455-024-K
浏览量:127
品牌:Trevigen
服务
全国联保
正品保证
正规发票
签订合同
商品描述

Description

Cultrex®BasementMembraneExtract(BME)isasolubleformofbasementmembranepurifiedfromEngelbreth-Holm-Swarm(EHS)tumor.Thisextractprovidesanaturalextracellularmatrixhydrogelthatpolymerizesat37°Ctoformareconstitutedbasementmembrane.Basementmembranesarecontinuoussheetsofspecializedextracellularmatrixthatformaninterfacebetweenendothelial,epithelial,muscle,orneuronalcellsandtheiradjacentstromaandthatplayanessentialroleintissueorganizationbyinfluencingcelladhesion,migration,proliferation,anddifferentiation.ThemajorcomponentsofBMEincludelaminin,collagenIV,entactin,andheparinsulfateproteoglycans.

TheCultrex®BME CellInvasionAssayprovidesatoolforassessingcellinvasionthroughareconstitutedbasementmembraneandisavailablein24and96wellformats.

Catalog#3455-024-Kincludes:
CatalogNumberDescriptionQty
3455-096-025XBMECoatingSolution1
3455-096-0310XCoatingBuffer1
4892-010-01CalceinAM1
3455-024-01CellInvasionInserts1
3455-096-0425XCellWashBuffer1
3455-096-0510XCellDissociationSolution1
Catalog#3455-096-Kincludes:
CatalogNumberDescriptionQty
3455-096-025XBMECoatingSolution1
3455-096-0310XCoatingBuffer1
4892-010-01CalceinAM1
3455-096-01CellInvasionChamber1
3455-096-0425XCellWashBuffer1
3455-096-0510XCellDissociationSolution1

HypermethylationoftheGABREtextasciitildemiR-452textasciitildemiR-224PromoterinProstateCancerPredictsBiochemicalRecurrenceafterRADIcalProstatectomy,
HelleKristensen,ChristaHaldrup,SiriStrand,KamillaMundbjerg,MartinM.Mortensen,KasperThorsen,MarieStampeOstenfeld,PeterJ.Wild,ChristianArsov,WolfgangGoering,TapioVisakorpi,LarsEgevad,JohanLindberg,HenrikGrönberg,SørenHøyer,MichaelBorre,TorbenF.Ørntoft,andKarinaD.Sørensen
Clin.CancerRes.,Apr2014;20:2169–2181.
http://clincancerres.aacrjournals.org/cgi/content/abstract/20/8/2169

1α,25-DihydroxyvitaminD3InhibitsEsophagealSquamousCellCarcinomaProgressionbyReducingIL6Signaling

Ping-TsungChen,Ching-ChuanHsieh,Chun-TeWu,Tzu-ChenYen,Paul-YangLin,Wen-ChengChen,andMiao-FenChen
Mol.CancerTher.,Jun2015;14:1365–1375.
http://mct.aacrjournals.org/cgi/content/abstract/14/6/1365

ReciprocalregulationofaminoacidimportandepigeneticstatethroughLat1andEZH2
StephenGDann,MichaelRyskin,AnthonyMBarsotti,JonathonGolas,CelineShi,MiriamMiranda,ChristineHosselet,LuannaLemon,JudyLucas,MahaKarnoub,FangWang,JeremySMyers,ScottJGarza,MaximillianTFollettie,KennethGGeles,AnkeKlippel,RobertARollins,andValeriaRFantin
EMBOJ.,Jul2015;34:1773–1785.
http://EMBOJ.embopress.org/cgi/content/abstract/34/13/1773

“Semaphorin3Dautocrinesignalingmediatesthemetastaticroleof
annexinA2inpancreaticcancer”

“KellyFoley,AgnieszkaA.Rucki,QianXiao,DongerZhou,AshleyLeubner,GuanglanMo,Jennifer
Kleponis,AnnieA.Wu,RajniSharma,QingguangJiang,RobertA.Anders,ChristineA.Iacobuzio-
Donahue,KatherineA.Hajjar,AnirbanMaitra,ElizabethM.Jaffee,andLeiZheng”
Sci.Signal.,Aug2015;8:ra77.
http://stke.sciencemag.org/cgi/content/abstract/sigtrans;8/388/ra77

EukaryoticTranslationInitiationFactor5A(EIF5A)RegulatesPancreaticCancerMetastasisbyModulatingRhoAandRho-associatedKinase(ROCK)ProteinExpressionLevels
KenFujimura,SunkyuChoi,MeghanWyse,JanStrnadel,TracyWright,andRichardKlemke
J.Biol.Chem.,Dec2015;290:29907–29919.
http://www.jbc.org/cgi/content/abstract/290/50/29907

“ExtracellularandLuminalpHRegulationbyVacuolarH+-ATPase
IsoformExpressionandTargetingtothePlasmaMembraneand
Endosomes”

GinaA.Smith,GarethJ.Howell,ClairPhillips,StephenP.Muench,SreenivasanPonnambalam,andMichaelA.Harrison
J.Biol.Chem.,Apr2016;291:8500–8515.
http://www.jbc.org/cgi/content/abstract/291/16/8500

TheMCT4Gene:ANovel,PotentialTargetforTherapyofAdvancedProstateCancer

“StephenYiuChuenChoi,HuiXue,RebeccaWu,LadanFazli,DongLin,ColinC.Collins,MartinE.Gleave,
PeterW.Gout,andYuzhuoWang”
Clin.CancerRes.,Jun2016;22:2721–2733.
http://clincancerres.aacrjournals.org/cgi/content/abstract/22/11/2721

Trevigen公司位于美国马里兰州的高科技走廊,是一家有12年历史、成长迅速的生物技术公司,其产品和技术的发展方向主要在癌症研究领域,重点强调细胞凋亡、DNA损伤和修复,以及癌症细胞功能和行为。Trevigen品牌的分销商遍及北美,欧洲和环太平洋地区。关于DNA的损伤分析技术的研究,Trevigen获得美国国立卫生研究院(NIH)的SBIR项目资助。